anti-CMKLR1 antibody

Este producto es parte de CMKLR - Chemerin chemokine-like receptor
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
anti-CMKLR1 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab10506
tested applications
ELISA, WB, IF

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

Category
Primary Antibodies
Immunogen Target
Chemokine-like receptor 1
Host
Rabbit
Reactivity
mouse,rat
Recommended Dilution
WB: 1:500-1:2000; IF: 1:50-1:200
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
55 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB, IF
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
Q99788
Alias
CMKLR1,CHEMERINR,ChemR23,DEZ,ERV1,RVER1,chemokine receptor-like 1,Gpcr27,G-protein coupled receptor DEZ,resolvin E1 receptor,RVER1,tazarotene induced gene 2 receptor,TIG2 receptor
Background
Antibody anti-CMKLR1
Status
RUO
Note
This product is for research use only.

(CMKLR1), also known as ChemR23, is a G-protein-coupled receptor (GPCR) primarily activated by chemerin, a protein involved in immune responses and adipose tissue regulation. CMKLR1 is expressed in immune cells, such as macrophages, dendritic cells, and natural killer (NK) cells, as well as in adipocytes and smooth muscle cells. Its signaling plays a crucial role in inflammation and immune cell migration, especially during tissue injury or infection. CMKLR1 activation promotes macrophage recruitment to inflamed tissues, aiding in immune responses and wound healing. It also influences adipogenesis and metabolic regulation, contributing to energy balance and insulin sensitivity. CMKLR1 is implicated in cardiovascular diseases, where it regulates vascular inflammation and smooth muscle contraction, affecting blood pressure and vessel remodeling. Dysregulation of CMKLR1 signaling has been linked to metabolic disorders such as obesity, type 2 diabetes, and chronic inflammation. Moreover, CMKLR1 is being investigated as a target in autoimmune diseases and cancers, where its modulation could impact tumor microenvironments and immune evasion. The receptor's dual role in metabolic homeostasis and immune regulation positions it as a potential target for novel therapeutic interventions.

Related Products

FNab10506

anti-CMKLR1 antibody

Ver Producto
abx013946

Chemokine Like Receptor 1 (CMKLR1) Antibody

Rabbit polyclonal antibody against CMKLR1 protein. Immunogen region is Internal.

Ver Producto
abx031448

Chemokine Like Receptor 1 (CMKLR1) Antibody

Orphan receptor. Could be a chemotactic peptide receptor. May have a function in bone metabolism. Acts as a coreceptor for several SIV strains (SIVMAC316, SIVMAC239, SIVMACL7E-FR and SIVSM62A), as well as a primary HIV-1 strain (92UG024-2).

Ver Producto